In the ever-evolving landscape of the pharmaceutical industry, market access has become a critical factor in the success of new therapies and products. Gaining reimbursement and securing formulary positioning are essential for ensuring patient access
In the fiercely competitive pharmaceutical industry, an effective influence strategy is paramount for achieving market access and commercial success. Regional key decision makers, such as formulary committees, reimbursement authorities, and healthcare administrators, hold significant sway
Relationships are the key to success, and building a strong network of advisors can be the difference between a stagnant business and one that thrives. In this case study, we’ll explore the Orbital Theory of
In today’s dynamic healthcare landscape, relying solely on syndicated Key Opinion Leader (KOL) databases is no longer sufficient for pharmaceutical companies aiming to establish themselves as industry leaders. As disease management evolves and personalized treatment
Due to the rapidly changing landscape of the pharmaceutical industry, maximizing influence within the market remains of utmost importance. Both Key Opinion Leaders (KOLs) and Digital Opinion Leaders (DOLs) serve as surrogates of information to
Neolytica aims to provide advanced data analytics solutions to pharmaceutical, biotech, and medical device companies. Leveraging artificial intelligence and machine learning technologies, Neolytica offers actionable insights and predictive analytics to drive informed decision-making and optimize
Morristown, NJ – March 17, 2022 – Neolytica, a healthcare analytics firm, today announced that it has experienced explosive business growth over the past year. The company has added numerous enterprise-level customers to its roster,
The AI Journal Interview: Badal Shah, Managing Director at Neolytica – Your Health Analytics Partner
The company aims to provide customized solutions for key opinion leader (KOL) identification and mapping, help medical and commercial teams collaborate, and improve medical education within biopharma companies.